Alteri Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Buy
3,143
+77
+3% +$78.7K 1.04% 15
2026
Q1
$2.82M Buy
3,066
+24
+0.8% +$24.3K 0.91% 19
2025
Q4
$3.27M Sell
3,042
-108
-3% -$103K 1.06% 17
2025
Q3
$2.4M Buy
3,150
+156
+5% +$116K 0.83% 20
2025
Q2
$2.33M Sell
2,994
-49
-2% -$38.1K 0.91% 18
2025
Q1
$2.51M Buy
3,043
+52
+2% +$43.3K 1.11% 15
2024
Q4
$2.31M Buy
+2,991
New +$2.48M 0.64% 21

Other funds holding LLY

Alteri Wealth's LLY Position: Q2 2026 in Review

Alteri Wealth increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $78.7K and bringing the position to 3,143 shares worth $3.77M. The position accounts for 1.04% of the portfolio, ranked #15.

Alteri Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,015 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alteri Wealth held 3,143 shares of Eli Lilly worth $3.77M as of Q2 2026.
  • Alteri Wealth bought 77 Eli Lilly shares in Q2 2026, an estimated $78.7K.
  • Eli Lilly made up 1.04% of Alteri Wealth's portfolio in Q2 2026, its #15 holding.
  • Alteri Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,015 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.